Hiberix and Immunocompromised

• Generic Name: haemophilus b conjugate (prp-t) vaccine
• Dosage Forms: injection, powder, lyophilized, for solution
• Other Brand Names: ActHIB, Hiberix

Hiberix is a brand of haemophilus B vaccine. Haemophilus influenzae type B (Hib) is a type of influenza (flu) caused by bacteria. Haemophilus B influenzae bacteria can infect the lungs or throat, and can also spread to the blood, bones, joints, brain, or spinal cord. The bacteria infection can cause breathing problems or meningitis, and these infections can be fatal.

Hiberix is used to prevent haemophilus B in children, and is sometimes combined with vaccines to protect against other diseases. Hiberix is given to children between the ages of 2 months and 18 months old.

Hiberix works by exposing your child to a small amount of the bacteria or a protein from the bacteria, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body, and will not protect against other types of influenza.

Hiberix is not for use in children younger than 6 weeks. When used in combination with certain diphtheria vaccines, this vaccine may not be used in children younger than 15 months.

Like any vaccine, Hiberix may not provide protection from disease in every person.